Intra-Cellular Therapies ... (ITCI)
NASDAQ: ITCI
· Real-Time Price · USD
131.87
0.00 (0.00%)
At close: Apr 01, 2025, 3:59 PM
Intra-Cellular Therapies Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -127.53 | -73.5 | -108.69 | -108.44 | -60.32 | -51.61 | -35.5 | -29.23 | -33.65 | -20.41 | -16 | -19.61 | -12.44 | -9.86 | -12.06 | -13.02 |
PEG Ratio | 0.39 | -1.31 | n/a | 2.32 | -3.02 | 1.16 | 16.33 | -1.63 | 1.07 | 0.57 | -1.13 | 0.76 | -1.18 | -0.84 | -0.39 | 0.90 |
PS Ratio | 43.24 | 44.18 | 43.70 | 45.65 | 52.44 | 39.81 | 55.17 | 54.38 | 57.35 | 60.78 | 97.56 | 162.79 | 167.13 | 140.37 | 174.45 | 176.30 |
PB Ratio | 7.50 | 6.76 | 6.16 | 11.03 | 11.66 | 8.34 | 10.01 | 8.21 | 7.64 | 6.37 | 7.44 | 7.14 | 10.20 | 6.23 | 5.99 | 4.49 |
P/FCF Ratio | -680.86 | -284.31 | 14.42K | -193.86 | -3.34K | -196.1 | -165.08 | -85.76 | -128.03 | -81.69 | -56.61 | -67.83 | -58.27 | -38.11 | -55.88 | -57.5 |
P/OCF Ratio | -658.63 | -291.77 | 13.01K | -193.86 | -3.35K | -198.18 | -165.08 | -85.76 | -127.94 | -81.87 | -56.68 | -68.29 | -58.27 | -38.26 | -55.89 | -57.5 |
OCF/S Ratio | -0.07 | -0.15 | 0.00 | -0.24 | -0.02 | -0.2 | -0.33 | -0.63 | -0.45 | -0.74 | -1.72 | -2.38 | -2.87 | -3.67 | -3.12 | -3.07 |
Debt / Equity Ratio | 0.01 | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.03 | 0.06 | 0.05 | 0.05 | 0.05 |
Quick Ratio | 6.23 | 7.51 | 7.69 | 5.00 | 5.31 | 6.40 | 7.13 | 8.52 | 8.58 | 9.51 | 10.82 | 14.23 | 8.61 | 10.52 | 11.77 | 16.16 |
Current Ratio | 6.36 | 7.66 | 7.81 | 5.12 | 5.41 | 6.81 | 7.58 | 8.87 | 8.87 | 9.81 | 11.17 | 14.36 | 8.76 | 10.69 | 11.93 | 16.35 |
Asset Turnover | 0.15 | 0.13 | 0.12 | 0.19 | 0.18 | 0.18 | 0.15 | 0.13 | 0.12 | 0.09 | 0.07 | 0.04 | 0.05 | 0.04 | 0.03 | 0.02 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -0.01 | -0.02 | -0.01 | -0.03 | -0.05 | -0.04 | -0.07 | -0.07 | -0.06 | -0.08 | -0.12 | -0.09 | -0.21 | -0.16 | -0.12 | -0.09 |
Return on Assets | -0.01 | -0.02 | -0.01 | -0.02 | -0.04 | -0.03 | -0.06 | -0.06 | -0.05 | -0.07 | -0.1 | -0.08 | -0.17 | -0.14 | -0.11 | -0.08 |
Return on Invested Capital | -0.02 | -0.03 | -0.02 | -0.03 | -0.06 | -0.05 | -0.08 | -0.07 | -0.06 | -0.08 | -0.11 | -0.09 | -0.19 | -0.15 | -0.12 | -0.08 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.90 | 0.91 | 0.93 | 0.93 | 0.92 | 0.93 | 0.93 | 0.93 | 0.92 | 0.92 | 0.92 | 0.91 | 0.90 | 0.91 | 0.89 | 0.91 |
Net Profit Margin | -0.08 | -0.15 | -0.1 | -0.11 | -0.22 | -0.19 | -0.39 | -0.47 | -0.43 | -0.74 | -1.52 | -2.08 | -3.36 | -3.56 | -3.62 | -3.39 |
Pretax Profit Margin | -0.09 | -0.15 | -0.1 | -0.1 | -0.21 | -0.19 | -0.39 | -0.46 | -0.5 | -0.74 | -1.57 | -2.07 | -3.36 | -3.56 | -3.62 | -3.39 |
Operating Profit Margin | -0.15 | -0.22 | -0.17 | -0.14 | -0.26 | -0.24 | -0.43 | -0.51 | -0.54 | -0.77 | -1.6 | -2.09 | -3.37 | -3.58 | -3.64 | -3.42 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -0.15 | -0.22 | -0.17 | -0.14 | -0.26 | -0.24 | -0.43 | -0.51 | -0.54 | -0.77 | -1.59 | -2.09 | -3.36 | -3.57 | -3.63 | -3.41 |